http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9955305-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7fc8fdb9ed0cf66b53be4ced1d5ae47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c262e30f5923da0714011378481eef5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99f6d79539acc80a579e2b16c32faf60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab3456bd89e21218adc37f4a0010e4e8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 1999-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61e9ba7c2a98ff383d9d88b2669b9995
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b0457fc5c8883fabb91c88763a84bd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43aef7926b15b3670415226a508e4448
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2591e90aae9d9ec44baaabc28a7a8b5
publicationDate 1999-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9955305-A2
titleOfInvention Controlled release peroral compositions of levosimendan
abstract The invention relates to peroral pharmaceutical compositions which release levosimendan in a controlled fashion with reduced occurrence of undesired effects. Levosimendan, or (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile, is useful in the treatment of congestive heart failure.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03004035-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9889133-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11701355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11191764-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11607412-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9320738-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10449194-B2
priorityDate 1998-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9916443-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9321921-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9212135-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0383449-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10989605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226461901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414506150
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54355681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9816296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129232388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22141804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57089479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415729372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135868638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92024010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127940400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231812172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231812170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10131079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127688846
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448718630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135922523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226459474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557062
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414506151

Total number of triples: 73.